These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32769142)

  • 1. Overcoming Waning Immunity in Pertussis Vaccines: Workshop of the National Institute of Allergy and Infectious Diseases.
    Damron FH; Barbier M; Dubey P; Edwards KM; Gu XX; Klein NP; Lu K; Mills KHG; Pasetti MF; Read RC; Rohani P; Sebo P; Harvill ET
    J Immunol; 2020 Aug; 205(4):877-882. PubMed ID: 32769142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roads to the development of improved pertussis vaccines paved by immunology.
    Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH
    Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.
    Bolotin S; Harvill ET; Crowcroft NS
    Pathog Dis; 2015 Nov; 73(8):ftv057. PubMed ID: 26253079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis: Where did we go wrong and what can we do about it?
    Locht C
    J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Immune Responses to Pertussis Vaccines.
    Ausiello CM; Mascart F; Corbière V; Fedele G
    Adv Exp Med Biol; 2019; 1183():99-113. PubMed ID: 31342460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis.
    Warfel JM; Zimmerman LI; Merkel TJ
    Clin Vaccine Immunol; 2016 Jan; 23(1):47-54. PubMed ID: 26561389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology.
    Sheridan SL; Frith K; Snelling TL; Grimwood K; McIntyre PB; Lambert SB
    Expert Rev Vaccines; 2014 Sep; 13(9):1081-106. PubMed ID: 25093268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whither pertussis?
    Snelling TL; Waddington CS
    Expert Rev Anti Infect Ther; 2015 Feb; 13(2):145-8. PubMed ID: 25426699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Licensed pertussis vaccines in the United States. History and current state.
    Klein NP
    Hum Vaccin Immunother; 2014; 10(9):2684-90. PubMed ID: 25483496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis vaccines and the challenge of inducing durable immunity.
    Warfel JM; Edwards KM
    Curr Opin Immunol; 2015 Aug; 35():48-54. PubMed ID: 26091979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertussis vaccines: state-of-the-art and future trends.
    Tefon BE; Özcengiz E; Özcengiz G
    Curr Top Med Chem; 2013; 13(20):2581-96. PubMed ID: 24066885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.
    Hegerle N; Dore G; Guiso N
    Vaccine; 2014 Nov; 32(49):6597-600. PubMed ID: 25312274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a
    da Silva Antunes R; Quiambao LG; Sutherland A; Soldevila F; Dhanda SK; Armstrong SK; Brickman TJ; Merkel T; Peters B; Sette A
    J Immunol Res; 2020; 2020():8202067. PubMed ID: 32322598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.
    Valentini D; Ferrara G; Advani R; Hallander HO; Maeurer MJ
    BMC Immunol; 2015 Jul; 16():40. PubMed ID: 26129684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis of adults and infants.
    von König CH; Halperin S; Riffelmann M; Guiso N
    Lancet Infect Dis; 2002 Dec; 2(12):744-50. PubMed ID: 12467690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune persistence after pertussis vaccination.
    Chen Z; He Q
    Hum Vaccin Immunother; 2017 Apr; 13(4):744-756. PubMed ID: 28045580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating
    de Graaf H; Gbesemete D; Gorringe AR; Diavatopoulos DA; Kester KE; Faust SN; Read RC
    BMJ Open; 2017 Oct; 7(10):e018594. PubMed ID: 29025851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB
    Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.